Hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Our findings provide an unprecedented view of the human FPN1 outward-facing structure and the particular function of the so-called "gating residues" in the mechanism of iron export.-Guellec, J., Elbahnsi, A., Le Tertre, M., Uguen, K., Gourlaouen, I., Férec, C., Ka, C., Callebaut, I., Le Gac, G. Molecular model of the ferroportin intracellular gate and implications for the human iron transport cycle and hemochromatosis type 4A.
|
31690120 |
2019 |
Hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
In the present study, we tried to investigate the frequency and pathogenicity of the SLC40A1 p.Y333H mutation in haemochromatosis in China.
|
30500107 |
2019 |
Hemochromatosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
Mutations in SLC40A1 (also known as FPN1; encoding ferroportin) that prevent hepcidin-ferroportin binding also cause haemochromatosis.
|
29620054 |
2018 |
Hemochromatosis
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Non-mutagenic Suppression of Enterocyte Ferroportin 1 by Chemical Ribosomal Inactivation via p38 Mitogen-activated Protein Kinase (MAPK)-mediated Regulation: EVIDENCE FOR ENVIRONMENTAL HEMOCHROMATOSIS.
|
27445333 |
2016 |
Hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
SLC40A1 mutations fall into two functional categories (loss- versus gain-of-function) underlying two distinct clinical entities (hemochromatosis type 4A versus type 4B).
|
24714983 |
2014 |
Hemochromatosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
Mutations in the HFE, TFR2, and SLC40A1 genes in patients with hemochromatosis.
|
22890139 |
2012 |
Hemochromatosis
|
0.400 |
Biomarker
|
disease |
CTD_human |
To screen exon-by-exon DNA sequences of HFE, HJV, HAMP, TFR2 and SLC40A1 genes to characterize the molecular basis of HH in a sample of the Brazilian population.
|
21411349 |
2011 |
Hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Does the SLC40A1 gene modify HFE-related haemochromatosis phenotypes?
|
18820912 |
2009 |
Hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
The second subgroup of hemochromatosis is caused by autosomal dominant mutations in the SLC40A1 gene encoding the iron exporter ferroportin with distinctive features.
|
19907151 |
2009 |
Hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the SLC40A1 gene result in a dominant genetic disorder [ferroportin disease; hereditary hemochromatosis type (HH) IV], characterized by iron overload with two different clinical manifestations, normal transferrin saturation with macrophage iron accumulation (the most prevalent type) or high transferrin saturation with hepatocyte iron accumulation (classical hemochromatosis phenotype).
|
17997113 |
2008 |
Hemochromatosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
We used a standard 96-well microplate with a single PCR condition in an adaptation of the SCAIP (single-condition amplification with internal primer) method to sequence the HFE (hemochromatosis), HAMP (hepcidin antimicrobial peptide), HFE2/HJV [hemochromatosis type 2 (juvenile)], SLC40A1 (ferroportin), and TFR2 (transferrin receptor 2) genes, and the 5' untranslated region of the FTL (ferritin, light polypeptide) gene.
|
17951290 |
2007 |
Hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
We conclude that this patient represents a unique example of hemochromatosis due to a single base-pair mutation of SLC40A1 that results in aberrant splicing and truncation of ferroportin.
|
18160816 |
2007 |
Hemochromatosis
|
0.400 |
Biomarker
|
disease |
CTD_human |
Wild-type and mutant ferroportins do not form oligomers in transfected cells.
|
16457665 |
2006 |
Hemochromatosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
Mutations in the iron exporter ferroportin (Fpn) (IREG1, SLC40A1, and MTP1) result in hemochromatosis type IV, a disorder with a dominant genetic pattern of inheritance and heterogeneous clinical presentation.
|
15956209 |
2005 |
Hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Recently, ferroportin 1 mutations leading to hemochromatosis (HFE4) have been identified.
|
15935710 |
2005 |
Hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
LHGDN |
A novel ferroportin disease in a Japanese patient.
|
15942076 |
2005 |
Hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the gene encoding ferroportin 1, a cellular iron exporter, are responsible for this iron storage disease, inherited as an autosomal dominant trait.
|
15986403 |
2005 |
Hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Type IV hemochromatosis is associated with dominant mutations in the SLC40A1 gene encoding ferroportin (FPN).
|
15692071 |
2005 |
Hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
LHGDN |
Type IV hemochromatosis is associated with dominant mutations in the SLC40A1 gene encoding ferroportin (FPN).
|
15692071 |
2005 |
Hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
LHGDN |
Autosomal dominant hereditary hemochromatosis associated with a novel ferroportin mutation and unique clinical features.
|
15727899 |
2005 |
Hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
LHGDN |
It was suggested that the mutation in the ferroportin 1 may be related to hemochromatosis of this patient.
|
15897636 |
2005 |
Hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Dominant hemochromatosis due to N144H mutation of SLC11A3: clinical and biological characteristics.
|
12547233 |
2003 |
Hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
LHGDN |
A study of genes that may modulate the expression of hereditary hemochromatosis: transferrin receptor-1, ferroportin, ceruloplasmin, ferritin light and heavy chains, iron regulatory proteins (IRP)-1 and -2, and hepcidin.
|
11783942 |
2003 |
Hemochromatosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
Duodenal expression of DMT1 (IRE) and Ireg1 was similar in haemochromatosis patients and iron replete subjects but in haemochromatosis patients with elevated serum ferritin concentrations, both DMT1 (IRE) and Ireg1 expression were inappropriately increased relative to serum ferritin concentration.
|
12801950 |
2003 |
Hemochromatosis
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Hepatic IREG1 expression was greatly upregulated in patients with haemochromatosis (1.8-fold, 95% CI 1.5-2.2; p=0.002).
|
12606179 |
2003 |